Bluejay Diagnostics (BJDX) Asset Writedowns and Impairment (2022 - 2026)

Bluejay Diagnostics' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $2880.0 for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $2880.0; the TTM figure through Mar 2026 stood at $47808.0 (changed N/A YoY), while the FY2025 annual figure was $42937.0, up 1158.78% from the prior year.
• Asset Writedowns and Impairment came in at $2880.0 for Q1 2026 at Bluejay Diagnostics, down from $16231.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $27192.0 in Q4 2022 to a low of $2486.0 in Q4 2024.
• A 4-year average of $15000.0 and a median of $16231.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 552.9% in 2025 and fell as far as 552.9% in 2025.
• Bluejay Diagnostics' Asset Writedowns and Impairment stood at $27192.0 in 2022, then sank by 90.86% to $2486.0 in 2024, then surged by 552.9% to $16231.0 in 2025, then sank by 82.26% to $2880.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $2880.0, $16231.0, and $26211.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison